Free Newsletter
Researchers find new tool to slow antibiotic resistance
Northwestern University microbiologists Luciano Marraffini and Erik Sontheimer report in an upcoming issue of Science that they believe they have found a way to prolong the effectiveness of antibiotics against the growing threat of lethal bacteria like methicillin-resistant Staphylococcus aureus.
The researchers say that a mechanism known as CRISPR interference, which bacteria uses to block the acquisition of new genes gained from indiscriminate interactions, can also be used to stop MRSA from spreading resistance to antibiotics.
"The cool thing about CRISPR is that it provides acquired immunity," Rotem Sorked, a molecular biologist at Weizmann Institute of Science tells New Scientist. "Bacteria learn how to defend themselves against phage and plasmid infections - in a way analogous to the way our immune system learns how to fight pathogens."
- read the report in New Scientist
- check out the story in Genetic Engineering News
Related Articles:
New 'superbug' approach relies on decoy DNA
Clues shed light on fighting lethal MRSA strain
Trail of genetic clues leads to new antibiotics
Super-resistant soil bacteria can thrive on antibiotics
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FierceBiotech Research email newsletter for FREE!
Be the first to comment